This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

2 - 4 November 2021
Delivered in GMT time zone

2 - 4 November 2021
Delivered in GMT time zone

COVID-19: Transforming Clinical Trials For Good

Discover How Clinical Development Has Evolved, Advanced And Transformed Throughout The Global Pandemic

Explore real world examples and expert perspectives through case studies and interactive panel discussions with live Q&A

Explore The Impact Of COVID-19 On Clinical Development With Real World Insights And Leading Perspectives

Implement Key Learnings From The Global Pandemic

  • Cancer Research UK Centre for Drug Development share learnings from running a nationally prioritised COVID-19 trial
  • Gain practical advice on how to support a remote clinical team's experience and productivity during a pandemic with insights from Tufts University School of Medicine
  • Explore the process changes triggered by the COVID-19 pandemic as experienced by Novartis Pharma GmbH
  • Roche share advice on how to use Innovative Clinical Trial Methods to increase the efficiency of drug development and allow for faster patient access

Participate In Interactive Panel Discussions Addressing:

  • How much are Pharma Companies Tackling Diversity Issues?
  • David and Goliath – Is There Still a Place for Small to Mid-sized CROs in Today’s Complex Clinical Trial Arena?
  • Impact of Running Clinical Trials during the Pandemic and Lessons Learnt

Combating Coronavirus

Last year's "Coronavirus Panel Discussion: Lessons learnt and challenges ahead" raised some important challenges and points for consideration.

Join us this year to learn how far the global clinical community has come, hear about the latest developments and discuss how COVID-19 has transformed the clinical trials landscape forever.